• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi March 22 On the eve of March 24, marked as World TB Day, Eli Lilly and Company, committed an additional $50 million to fight Multi-Drug Resistant Tuberculosis (MDR-TB).

The campaign is carried out in an international partnership with 14 public and private organisations around the world, and takes the company's global financial commitment to the cause to $120 million since 2003.

According to a recent World Health Organisation report, 1.8 million people get infected annually in India, which is believed to have the highest number of people suffering from TB infection. "Every two minutes, a person dies from TB in India. India has more cases of TB than any other country in the world," said Mr Sandeep Gupta, Chairman and Managing Director, Eli Lilly India in an official statement.

The company does not sell any TB drugs in India but provides WHO-approved programmes with its two MDR-TB drugs at subsidised rates.

More Stories on : Society & Development | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
AstraZeneca's new lab to host key research work

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line